Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07015814

Comparative Evaluation of Glycemic Index of Different Types of Jaggery Produced Locally in Pakistan

This study aims to evaluate and compare the glycemic index (GI) of various types of jaggery by measuring their effect on blood glucose levels in healthy individuals. Using glucose as the reference standard , the objective is to determine how different jaggery types influence postprandial blood sugar response.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rehman Medical Institue

Peshawar, Khyber Pakhtunkhwa, 092, Pakistan

About this study

This study aims to evaluate and compare the glycemic index (GI) of various types of jaggery by measuring their effect on blood glucose levels in healthy individuals. Using glucose as the reference standard , the objective is to determine how different jaggery types influence postprandial blood sugar response. The findings will help identify which types of jaggery have lower glycemic impact, contributing to better dietary choices for glycemic control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants should be clinically healthy, as determined by their medical records and verbal history. Only individuals with normal fasting blood glucose levels (70-99 mg/dL) during screening will be eligible -

Exclusion criteria

1) Participants must not have any chronic disease, not be taking any medications that influence carbohydrate metabolism (such as corticosteroids or metformin), and should be non-smokers and non-alcoholics.

  • Pregnant or lactating female participants, as well as any person with gastrointestinal, metabolic, or endocrine disease (e.g., thyroid disease, PCOS, IBD), will be excluded.
  • Also, subjects with a history of recent acute illness (within the last 2 weeks) will be deferred.

-

Treatment and study plan

Golden sugarcane jaggery

Other

Participants will consume a standardized portion of jaggery Type A providing 50 grams of available carbohydrates. Capillary blood glucose will be measured over a 2-hour postprandial period.

Dark brown sugarcane jaggery

Other

Participants will consume a standardized portion of jaggery Type B providing 50 grams of available carbohydrates. Capillary blood glucose will be measured over a 2-hour postprandial period.

Primary outcomes

  1. Glycemic Index (GI) of Different Types of Jaggery

    Time frame: Measured at multiple time points post-consumption (e.g., 0, 15, 30, 45, 60, 90, and 120 minutes) during each test session.

    The incremental area under the blood glucose response curve (iAUC) over 2 hours after consumption of each type of jaggery, expressed as a percentage of the glucose reference.

Secondary outcomes

  1. Postprandial Blood Glucose Response Curve

    Time frame: Same as primary outcome (0-120 minutes).

    Blood glucose levels at each time point following consumption of jaggery types and glucose, to assess the shape and peak of glycemic response.

Study contacts

Contact information is provided by the study sponsor or research team.

Naseer Ahmed

CONTACT

[email protected]

03305485960

Sponsors and collaborators

Lead sponsor

Rehman Medical Institute - RMI

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 11, 2025
Registry last updated
Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.